A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and ...

Dr. Hong’s longstanding commitment to innovation and compassion for his patients made him a pioneer in bringing the TULSA Procedure, a clinically proven, advanced prostate disease treatment, to ...

Revenue grew 87% year-over-year to a record $5.3 million in the third quarter of 2025. Gross margin increased 1,119 basis points year-over-year to 74.3% in Q3-2025. The Company’s TULSA-PRO ® qualified ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

In Gaza, a patient’s suffering does not end at diagnosis. The Israeli blockade has turned obtaining any medical supplies into ...

I OFTEN get questions about an uncomfortable bowel condition called diverticulosis. It’s common in those over 50 and is where ...

Through a collaboration with Edwards Lifesciences, Philips is rolling out new artificial intelligence tools designed to ...

BALTIMORE, Nov. 13, 2025 (GLOBAL NEWSWIRE) — The Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), and the Prostate Cancer Foundation (PCF) today ...

Rome Health is expanding its robotic surgery program to offer a new minimally invasive option for treating an enlarged ...

ROME — Rome Health is expanding its robotic surgery program to provide men with a new minimally invasive option to treat an ...

I’m a 64-year-old man who was recently diagnosed with an enlarged prostate after experiencing issues with frequent urination, ...

The global interventional oncology market size is expected to reach USD 4.38 billion by 2030, registering a CAGR of 8.55% from 2025 to 2030, according to a new report by Grand View Research, Inc. This ...